Moving Research and Management Forward for Men with Treatment-Resistant Metastatic Prostate Cancer

December 07, 2020

Researchers Oliver Sartor, MD (Tulane Cancer Center), Andrew Armstrong, MD, MSc (Duke University) and Rob Reiter, MD (UCLA), hosted an educational session at the American Society of Clinical Oncology meeting titled, “State-of-the-Art Management for the Patient with Castration-Resistant Prostate Cancer in 2012.” The research trio addresses questions, and more, online.

Also in News

Lindi Skin honors Dr. Kenneth M. Algazy
Lindi Skin honors Dr. Kenneth M. Algazy

January 05, 2023

Read More

Guest Post: The Kindness Campaign discusses Skincare during Immunotherapy

January 04, 2022

Read More

Why does Lindi Skin contain fragrances?

December 01, 2021

Fragrance is one of the key decisions to be made when creating any skincare products, and our team of doctors, formulators and skincare experts created our formulas with very explicit instructions to design the products without any unnecessary fragrances, dyes, or ingredients.   

However, the key word here is “unnecessary”. 

Read More

Liquid error (layout/theme line 316): Could not find asset snippets/afterpay.liquid